头颈癌患者治疗前神经认知与自述言语障碍的患病率:与人口学、行为及疾病相关因素的关联
基于荷兰头颈癌前瞻性队列(N≥444)的横断面设计,评估治疗前神经认知与言语障碍的估计患病率及其与人口学、行为及疾病因素的关系。客观评估显示中重度神经认知障碍率为4%至8%,6.5%患者报告高水平认知失误,46.1%报告言语障碍;喉部肿瘤患者自述言语功能较其他亚部位更差。
要点
- 客观评估的中重度神经认知障碍患病率为4%至8%。
- 6.5%患者报告高水平认知失误,46.1%报告言语障碍。
- 喉部肿瘤患者自述言语功能较其他亚部位更差。
核心结论
- 部分头颈癌患者在治疗前即存在神经认知与言语障碍,喉部肿瘤患者可能更为突出。
研究设计与样本
- 采用荷兰头颈癌前瞻性队列(Netherlands Quality of Life and Biomedical Cohort Study,N≥444)的横断面设计,调查治疗前障碍的估计患病率及其与所选人口学、行为及疾病相关因素的关系。
主要发现
- 客观评估显示中重度神经认知障碍率范围为4%至8%。
- 患者报告结局中,6.5%报告高水平认知失误,46.1%报告言语障碍。
- 喉部肿瘤患者自述言语功能较其他亚部位更差。
- 其他非言语结局与任何变量均无关。
- 患者报告的神经认知与言语功能呈适度相关,尤其在喉部肿瘤组。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Neurocognition and speech, relevant domains in head and neck cancer (HNC), may be affected pretreatment. However, the prevalence of pretreatment deficits and their possible concurrent predictors are poorly understood. METHODS: Using an HNC prospective cohort (Netherlands Quality of Life and Biomedical Cohort Study, N ≥ 444) with a cross-sectional design, we investigated the estimated prevalence of pretreatment deficits and their relationship with selected demographic, behavioral, and disease-related factors. RESULTS: Using objective assessments, rates of moderate-to-severe neurocognitive deficit ranged between 4% and 8%. From patient-reported outcomes, 6.5% of patients reported high levels of cognitive failures and 46.1% reported speech deficits. Patient-reported speech functioning was worse in larynx compared to other subsites. Other nonspeech outcomes were unrelated to any variable. Patient-reported neurocognitive and speech functioning were modestly correlated, especially in the larynx group. CONCLUSIONS: These findings indicate that a subgroup of patients with HNC shows pretreatment deficits, possibly accentuated in the case of larynx tumors.
引用
- Piai V, Jansen F, Dahlslätt K, et al. Prevalence of neurocognitive and perceived speech deficits in patients with head and neck cancer before treatment: Associations with demographic, behavioral, and disease-related factors. Head Neck. 2021. PMID: 34799885. doi:10.1002/hed.26930
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。